Munafa Stock Market Course + Intraday & FNO calls 
Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)
Technical Analysis Report for NASDAQ stock NTLA Intellia Therapeutics. Dated: 23 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics
Intellia Therapeutics Opened at 12.93 and Closed at: 13.11, which is 1.98% of previous session's close. It moved within a range of 12.66 and 13.34
The session was a Bullish session with an average volume of 3106900, which is 32.75% of previous session's volumes.
- There is some positive change in the short term trend, but its too soon to jump onto conclusions.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 5 days back on short term averages
Support for tomorrow is 12.89 and resistance for tomorrow is 13.57
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 12.73, 12.36 resistance for tomorrow's hourly charts is 13.41, 13.72
10 Day SMA for Intellia Therapeutics (NTLA) is 13.19 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Intellia Therapeutics (NTLA) is 13.48 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Intellia Therapeutics (NTLA) is 13.01 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 11.36 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Intellia Therapeutics is 12.59 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Intellia Therapeutics is at 13.48 and 200 DMA is at 12.59, while 50 DMA and 100 DMA are at 13.01 and 11.36 respectively
Intellia Therapeutics (NTLA) moving average of 20 SMA is at 13.48 and 20 EMA is at 13.19
| Date | Closing Price | 20 SMA | 20 EMA |
| 23 Mon Mar | 13.11 | 13.48 | 13.19 |
| 20 Fri Mar | 12.85 | 13.46 | 13.2 |
| 19 Thu Mar | 13.15 | 13.47 | 13.24 |
| 17 Tue Mar | 13.49 | 13.43 | 13.25 |
| 16 Mon Mar | 13.38 | 13.37 | 13.23 |
| 13 Fri Mar | 12.76 | 13.3 | 13.21 |
Intellia Therapeutics (NTLA) moving average of 50 SMA is at 13.01 and 50 EMA is at 12.79
| Date | Closing Price | 50 SMA | 50 EMA |
| 23 Mon Mar | 13.11 | 13.01 | 12.79 |
| 20 Fri Mar | 12.85 | 12.96 | 12.78 |
| 19 Thu Mar | 13.15 | 12.9 | 12.78 |
| 17 Tue Mar | 13.49 | 12.84 | 12.77 |
| 16 Mon Mar | 13.38 | 12.75 | 12.74 |
| 13 Fri Mar | 12.76 | 12.67 | 12.71 |
Intellia Therapeutics (NTLA) moving average of 100 SMA is at 11.36 and 100 EMA is at 12.6
| Date | Closing Price | 100 SMA | 100 EMA |
| 23 Mon Mar | 13.11 | 11.36 | 12.6 |
| 20 Fri Mar | 12.85 | 11.38 | 12.59 |
| 19 Thu Mar | 13.15 | 11.51 | 12.58 |
| 17 Tue Mar | 13.49 | 11.64 | 12.57 |
| 16 Mon Mar | 13.38 | 11.75 | 12.55 |
| 13 Fri Mar | 12.76 | 11.88 | 12.53 |
Intellia Therapeutics (NTLA) moving average of 200 SMA is at 12.59 and 200 EMA is at 12.71
| Date | Closing Price | 200 SMA | 200 EMA |
| 23 Mon Mar | 13.11 | 12.59 | 12.71 |
| 20 Fri Mar | 12.85 | 12.57 | 12.71 |
| 19 Thu Mar | 13.15 | 12.54 | 12.71 |
| 17 Tue Mar | 13.49 | 12.51 | 12.71 |
| 16 Mon Mar | 13.38 | 12.48 | 12.7 |
| 13 Fri Mar | 12.76 | 12.46 | 12.69 |
Intellia Therapeutics has performed better than Xtl Biopharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Vistagen Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Vistagen Therapeutics, about 13.11% more returns!
Intellia Therapeutics has performed better than Savara Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Staar Surgical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Staar Surgical, about 2.08% more returns!
Rockwell Medical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Rockwell Medical, about 11.25% more returns!
Intellia Therapeutics has performed better than Moleculin Biotech in short term. Holding Intellia Therapeutics could be a better choice for now!
Arbutus Biopharma has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Arbutus Biopharma, about 1.06% more returns!
Acadia Healthcare has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Acadia Healthcare, about 33.75% more returns!
Agenus Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Agenus Inc, about 20.58% more returns!
Intellia Therapeutics has performed better than Ardelyx Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Axsome Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Coherus Biosciences has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Coherus Biosciences, about 1.61% more returns!
Intellia Therapeutics has performed better than Cytosorbents Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Delcath Systems in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Dermira Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Dexcom Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Gossamer Bio in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Incyte Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics Technical analysis of indicators
Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term but the sell signal is initial and weak.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.19 and Intellia Therapeutics NTLA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NTLA Experts View which covers a lot of information including buying and selling signals
NTLA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
